Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lund

Showing results (741-750 of 826) with videos related to

Pageof 83
Sort By:
Cell|September 13, 2014
A dual program for translation regulation in cellular proliferation and differentiationHila Gingold, Disa Tehler, Nanna R Christoffersen, et al.
JACC. Heart Failure|October 30, 2025
Diet and Clinical Outcomes in a Heart Failure PopulationPhilip Joseph, Mahshid Dehghan, Justin A Ezekowitz, et al.
European Journal of Heart Failure|June 16, 2025
The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESCGabriele Fragasso, Davide Stolfo, Markus S Anker, et al.
JACC. Heart Failure|June 2, 2026
Ambulatory Stage C2D Heart Failure Definitions and Current Therapeutic Approaches: JACC: Heart Failure Position StatementShannon M Dunlay, Monica Colvin, Jennifer A Cowger, et al.
JACC. Heart Failure|September 28, 2024
Patiromer for Heart Failure Medication Optimization in Patients With Current or Past Hyperkalemia: DIAMOND SubanalysisAndrew J S Coats, Stefan D Anker, Lars H Lund, et al.
European Journal of Heart Failure|May 29, 2018
Advanced heart failure: a position statement of the Heart Failure Association of the European Society of CardiologyMaria G Crespo-Leiro, Marco Metra, Lars H Lund, et al.
American Journal of Nephrology|August 19, 2024
Patiromer-Facilitated Renin-Angiotensin-Aldosterone System Inhibitor Utilization in Patients with Heart Failure with or without Comorbid Chronic Kidney Disease: Subgroup Analysis of DIAMOND Randomized TrialMatthew R Weir, Patrick Rossignol, Bertram Pitt, et al.
JACC. Heart Failure|August 9, 2023
Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHFBertram Pitt, Deepak L Bhatt, Michael Szarek, et al.
European Journal of Heart Failure|June 27, 2023
Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: An analysis from the ESC-HFA Heart Failure Long-Term RegistryMarianna Adamo, Ovidiu Chioncel, Lina Benson, et al.
European Heart Journal|August 15, 2021
Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fractionAlice M Jackson, Pardeep S Jhund, Inder S Anand, et al.
Pageof 83

Showing results (741-750 of 826) with videos related to

Sort By:
Pageof 83
Cell|September 13, 2014
A dual program for translation regulation in cellular proliferation and differentiationHila Gingold, Disa Tehler, Nanna R Christoffersen, et al.
JACC. Heart Failure|October 30, 2025
Diet and Clinical Outcomes in a Heart Failure PopulationPhilip Joseph, Mahshid Dehghan, Justin A Ezekowitz, et al.
European Journal of Heart Failure|June 16, 2025
The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESCGabriele Fragasso, Davide Stolfo, Markus S Anker, et al.
JACC. Heart Failure|June 2, 2026
Ambulatory Stage C2D Heart Failure Definitions and Current Therapeutic Approaches: JACC: Heart Failure Position StatementShannon M Dunlay, Monica Colvin, Jennifer A Cowger, et al.
JACC. Heart Failure|September 28, 2024
Patiromer for Heart Failure Medication Optimization in Patients With Current or Past Hyperkalemia: DIAMOND SubanalysisAndrew J S Coats, Stefan D Anker, Lars H Lund, et al.
European Journal of Heart Failure|May 29, 2018
Advanced heart failure: a position statement of the Heart Failure Association of the European Society of CardiologyMaria G Crespo-Leiro, Marco Metra, Lars H Lund, et al.
American Journal of Nephrology|August 19, 2024
Patiromer-Facilitated Renin-Angiotensin-Aldosterone System Inhibitor Utilization in Patients with Heart Failure with or without Comorbid Chronic Kidney Disease: Subgroup Analysis of DIAMOND Randomized TrialMatthew R Weir, Patrick Rossignol, Bertram Pitt, et al.
JACC. Heart Failure|August 9, 2023
Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHFBertram Pitt, Deepak L Bhatt, Michael Szarek, et al.
European Journal of Heart Failure|June 27, 2023
Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: An analysis from the ESC-HFA Heart Failure Long-Term RegistryMarianna Adamo, Ovidiu Chioncel, Lina Benson, et al.
European Heart Journal|August 15, 2021
Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fractionAlice M Jackson, Pardeep S Jhund, Inder S Anand, et al.
Pageof 83